Median C-reactive protein (CRP) levels were more than twice as high in AML patients with FO as in AML without FO (6.5 mg/dl, range 2.0–24.2 vs. 2.9 mg/dl, range 0.3–16.0, p<0.001). The gene discussed is CRP; the disease is acute myeloid leukemia.